Top Stories

Gotham City believes investigations into bearish attack on Grifols will not result in significant financial blow

TOPICS:
grifols edificio

Posted By: The Corner 25th November 2025

Alphavalue/Divacons | Gotham City Research believes that the legal investigations stemming from its bearish attack on Grifols (GRF) in January 2024 will not result in a significant financial blow to the company, and has therefore ruled out making provisions for this possible contingency.

This position is maintained despite the fact that the Spanish pharmaceutical company has initiated legal proceedings in the United States in which it is claiming millions in compensation from Gotham City Research.

Grifols: Buy, Target Price €16.5/share.

About the Author

The Corner
The Corner has a team of on-the-ground reporters in capital cities ranging from New York to Beijing. Their stories are edited by the teams at the Spanish magazine Consejeros (for members of companies’ boards of directors) and at the stock market news site Consenso Del Mercado (market consensus). They have worked in economics and communication for over 25 years.